Suchergebnisse - "Safra, Tamar"

PubPharm (105)

61

Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma — a retrospective study

enthalten in: Gynecologic oncology | 2014

von Safra, T. | Shamai, S. | Greenberg, J. | +7

62

Delayed Neoplastic and Renal Complications in Women Receiving Long-term Chemotherapy for Recurrent Ovarian Cancer

enthalten in: Journal of the National Cancer Institute | 2013

von Muggia, F. | Cannon, T. | Safra, T. | +1

63

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma : tolerability and efficacy study--the Israeli experience

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2013

von Safra, T. | Berman, T. | Yachnin, A. | +6

64

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer

enthalten in: The New England journal of medicine | 2012

von Ledermann, J. | Harter, P. | Gourley, C. | +12

CommentIn: N Engl J Med. 2012 Jul 12;367(2):179; author reply 179-80. - PMID 22784123

65

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

enthalten in: The New England journal of medicine | 2012

von Ledermann, J. | Harter, P. | Gourley, C. | +12

66

Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Kaye, S. | Lubinski, J. | Matulonis, U. | +13

CommentIn: J Clin Oncol. 2012 Feb 1;30(4):347-50. - PMID 22203759

67

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2012

von Kaye, S. | Lubinski, J. | Matulonis, U. | +13

68

Squamous cell carcinoma of the oral cavity in nonsmoking women : a new and unusual complication of chemotherapy for recurrent ovarian cancer?

enthalten in: The oncologist | 2012

von Cannon, T. | Lai, D. | Hirsch, D. | +7

69

BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin

enthalten in: Molecular cancer therapeutics | 2011

von Safra, T. | Borgato, L. | Nicoletto, M. | +11

70

Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer

enthalten in: Journal of the National Cancer Institute | 2011

von Muggia, F. | Cannon, T. | Safra, T. | +1